Compare HRB & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HRB | TMDX |
|---|---|---|
| Founded | 1955 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.8B |
| IPO Year | 1994 | 2019 |
| Metric | HRB | TMDX |
|---|---|---|
| Price | $36.84 | $63.28 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $41.00 | ★ $148.22 |
| AVG Volume (30 Days) | ★ 2.4M | 1.6M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 5.34% | N/A |
| EPS Growth | 6.55 | ★ 382.18 |
| EPS | ★ 3.38 | 0.20 |
| Revenue | ★ $3,159,931,000.00 | $605,494,000.00 |
| Revenue This Year | $4.39 | $24.25 |
| Revenue Next Year | $3.21 | $18.75 |
| P/E Ratio | ★ $10.56 | $309.50 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $28.16 | $60.11 |
| 52 Week High | $59.05 | $156.00 |
| Indicator | HRB | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 64.49 | 20.50 |
| Support Level | $29.24 | N/A |
| Resistance Level | $44.16 | $131.86 |
| Average True Range (ATR) | 1.70 | 4.82 |
| MACD | 0.53 | -2.90 |
| Stochastic Oscillator | 87.93 | 6.64 |
H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives the majority of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.